AM

Ami Mihir Shah

Active Director Director DIN 03101049
DIN 03101049 First appointment Jan 2003 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Jan 2003
Shareholding value •••• Premium profile

About Ami Mihir Shah

Data last updated:

Ami Mihir Shah is a Director at Parnax Lab Limited (since 2015), Director at Naxpar Health Concepts Private Limited (since 2020) and Designated Partner at Naxpar Int Llp (since 2021), and holds 1 more current directorship. The companies operate in Pharma and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹195 Cr; the largest is Parnax Lab Limited at ₹189 Cr (FY 2025). Earlier, Ami Mihir Shah was a Director at Ciaa'b' Biotech Limited (2003–2014).

DIN 03101049
Primary Designation Director
Industry Pharma
First Appointment 14 Jan 2003
Oldest Company Age 44 yrs
Largest company Parnax Lab Limited · ₹189 Cr (FY 2025)
Combined revenue ₹195 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Parnax Lab Limited L36912MH1982PLC027925
Director31 Mar 20151982₹189 Cr (FY 2025)Active
Director21 Dec 20202004₹5.09 Cr (FY 2025)Active
Naxpar Int Llp AAX-6654
Designated Partner06 Jul 20212021Active
Designated Partner16 Mar 20182016Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ciaa'b' Biotech Limited U24233MH2003PLC138673
Director14 Jan 20032003Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Ami Mihir Shah

NameDINCompanyDesignation
Binoy Baiju Shah00440880Parnax Lab Limited , Naxpar Health Concepts Private Limited and 1 moreDirector
Binoy Baiju ShahParnax Lab LimitedCfo
Harish Sunderlal Panpalia10275561Parnax Lab LimitedDirector
Mihir Prakash Shah00387912Parnax Lab LimitedManaging Director
Mihir Prakash ShahParnax Lab LimitedCeo
Preet Vijay KukrejaParnax Lab LimitedCompany Secretary
Vijaykumar Shivaji Ayare06383445Parnax Lab LimitedDirector
Yogesh Kantilal Varia09186184Parnax Lab LimitedDirector
Pragna Prakash Shah01213147Naxpar Int LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Naxpar Int Llp
Naxpar Medicamentos Llp
Parnax Lab Limited
Naxpar Health Concepts Private Limited
Premium access

Shareholding and investment profile for Ami Mihir Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ami Mihir Shah

Ami Mihir Shah currently holds 4 directorships: Parnax Lab Limited (Director, since 31 Mar 2015, revenue ₹189 Cr (FY 2025)); Naxpar Health Concepts Private Limited (Director, since 21 Dec 2020, revenue ₹5.09 Cr (FY 2025)); Naxpar Int Llp (Designated Partner, since 06 Jul 2021); Naxpar Medicamentos Llp (Designated Partner, since 16 Mar 2018).

Ami Mihir Shah was first appointed on 14 Jan 2003 as Director at Ciaa'b' Biotech Limited. The most recent appointment on record is 06 Jul 2021 at Naxpar Int Llp.

The 2 current companies of Ami Mihir Shah that report revenue have a combined latest revenue of ₹195 Cr: Parnax Lab Limited ₹189 Cr (FY 2025); Naxpar Health Concepts Private Limited ₹5.09 Cr (FY 2025).

Ami Mihir Shah held 1 earlier board appointment: Ciaa'b' Biotech Limited (Director, 14 Jan 2003 to 01 Jan 2014).

The current boards of Ami Mihir Shah's companies include Binoy Baiju Shah (Parnax Lab Limited), Binoy Baiju Shah (Parnax Lab Limited), Harish Sunderlal Panpalia (Parnax Lab Limited), Mihir Prakash Shah (Parnax Lab Limited), Mihir Prakash Shah (Parnax Lab Limited), Preet Vijay Kukreja (Parnax Lab Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available